|
C4ORF34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.09310000004659E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.27700000005249E-06 |
| Normal-vs-Stage2 |
2.065000E-01 |
| Normal-vs-Stage3 |
1.863100E-03 |
| Normal-vs-Stage4 |
5.798900E-03 |
| Stage1-vs-Stage2 |
1.395440E-01 |
| Stage1-vs-Stage3 |
5.476800E-01 |
| Stage1-vs-Stage4 |
9.519200E-01 |
| Stage2-vs-Stage3 |
3.373800E-01 |
| Stage2-vs-Stage4 |
2.691600E-01 |
| Stage3-vs-Stage4 |
7.162600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30620000002602E-06 |
| Normal-vs-AfricanAmerican |
1.191900E-02 |
| Normal-vs-Asian |
2.304300E-02 |
| Caucasian-vs-AfricanAmerican |
6.020400E-01 |
| Caucasian-vs-Asian |
2.628400E-01 |
| AfricanAmerican-vs-Asian |
2.282600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.316300E-02 |
| Normal-vs-Female |
7.08480000000122E-07 |
| Male-vs-Female |
4.404300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.84940000003931E-07 |
| Normal-vs-Age(41-60Yrs) |
5.976500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.543700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.139600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.273800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.128000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.366200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.864800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.438000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.947400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.945400E-01 |
| Classical-VS-Follicular |
1.66271999999523E-05 |
| Classical-VS-Other |
1.085400E-01 |
| Classical-VS-Normal |
1.96670000285337E-08 |
| Tall-VS-Follicular |
1.412460E-02 |
| Tall-VS-Other |
1.059430E-01 |
| Tall-VS-Normal |
8.627500E-04 |
| Follicular-VS-Other |
8.393000E-01 |
| Follicular-VS-Normal |
7.459800E-01 |
| Other-VS-Normal |
9.421800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.503300E-03 |
| Normal-vs-N1 |
7.124100E-02 |
| N0-vs-N1 |
9.174400E-01 |
|
|
